alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2023275EN.01002501.xml

| 4.8.2023 | EN | Official Journal of the European Union | C 275/25 |
| --- | --- | --- | --- |

4.8.2023

EN

Official Journal of the European Union

C 275/25

---

New national side of euro coins intended for circulation

(2023/C 275/12)

Image 1

National side of the new commemorative 2-euro coin intended for circulation and issued by Croatia

Euro coins intended for circulation have legal tender status throughout the euro area. For the purpose of informing the public and all parties who handle the coins, the Commission publishes a description of the designs of all new coins (1). In accordance with the Council conclusions of 10 February 2009 (2), euro-area Member States and countries that have concluded a monetary agreement with the European Union providing for the issuing of euro coins are allowed to issue commemorative euro coins intended for circulation, provided that certain conditions are met, particularly that only the 2-euro denomination is used. These coins have the same technical characteristics as other 2-euro coins, but their national face features a commemorative design that is highly symbolic in national or European terms.

Issuing country: Croatia

Subject of commemoration: The introduction of the euro as the official currency of Croatia on 1 January 2023

Description of the design: The design features the inscriptions of the issuing country ‘HRVATSKA’ (Croatia) and the year of issuance ‘2023.’, depicted horizontally, as well as the words ‘ČLANICA EUROPODRUČJA’ (member of the euro area), which are inscribed along the outer edge of the coin’s core. These inscriptions symbolically form a stylised symbol of the euro ‘€’. The other central motive of the coin is Croatia's distinctive and recognisable symbol, the Croatian checkerboard, which represents part of the coat of arms of the Republic of Croatia.

The coin’s outer ring depicts the 12 stars of the European flag.

Estimated number of coins to be issued: 250 000

Date of issue: September 2023

---

(1)  See OJ C 373, 28.12.2001, p. 1 for the national faces of all the coins issued in 2002.

(2)  See the conclusions of the Economic and Financial Affairs Council of 10 February 2009 and the Commission Recommendation of 19 December 2008 on common guidelines for the national sides and the issuance of euro coins intended for circulation (OJ L 9, 14.1.2009, p. 52).

---
Study Title Report

Number

Test Substance Attachment File Name

In Vitro Mammalian

Chromosome Aberration

Test

In Vitro Mammalian

Chromosome Aberration

Unscheduled DNA

Synthesis (UDS) Test

Unscheduled DNA Synthesis

Test

Micronucleus and

Chromosome Aberration

Assays in Mouse Bone

Marrow Cells

Micronucleus and

Chromosome Aberration

Test

Local Lymph Node Assay

(LLNA) in Mice

LLNA Toxicity Test

Static, Acute, 96‐Hour

Limit Test with Rainbow

Trout, Oncorhynchus

mykiss

Trout Toxicity Test

Static, Acute, 48‐Hour

Limit Test with Daphnia

magna

Daphnia Toxicity Test

Static, 72‐Hour Growth

Inhibition Limit Test with

the Green Alga,

Pseudokirchneriella

subcapitata

Algae Toxicity Test

Urine Recovery Screen Urine Recovery Screen

Biopersistence and

Pharmacokinetic Screen in

the Rat

Biopersistence and

Pharmacokinetic Screen

In Vitro Male Rat S9 Screen In Vitro Male Rat S9 Screen

Repeated Dose Oral

Toxicity: 14‐Day Feeding

Study with in

Male Mice

Repeated Dose Oral Toxicity

Test #1

Repeated Dose Oral

Toxicity: 14‐Day Feeding

Study with and

in Male Mice

Repeated Dose Oral Toxicity

Test #2

This document lists the full study reports that will be submitted as PMN support documents for PMN

substance #2 and related substances.  There are no available studies for PMN substance #1.  For more

information about test substances, please see the summary of available test data attached to the PMN.  
Study Title Report

Number

Test Substance Attachment File Name

Bacterial Reverse Mutation

Test

Bacterial Reverse Mutation

Test

Ready Biodegradability

Modified Sturm Test

Ready Biodegradability Test

oral LD50

in the rat, tolerance tests

in the rabbit, ocular

irritation, primary skin

irritation

Oral LD50 in the rat,

tolerance tests, ocular

irritation, skin irritation in

the rabbit

oral LD50

in the rat, tolerance tests

in the rabbit, ocular

irritation, primary skin

irritation, repeated

application for 3 months

Oral LD50 in the rat,

tolerance test, ocular

irritation, skin irritation in

the rabbit, repeated

Bioconcentration and

bioaccumulation in

rainbow trout,

Oncorhynchus mykiss

Trout Bioconcentration and

bioaccumulation

Biopersistence screening

10‐dose oral gavage study

in rats with recovery

period

Rat Biopersistence screen

In vitro trout hepatocyte

bioaccumulation screen

In Vitro Trout

Bioaccumulation screen

Static, acute, 96‐hour

toxicity test with rainbow

trout, Oncorhynchus

mykiss

Trout toxicity test #2

Early life‐stage toxicity to

rainbow trout,

Oncorhynchus mykiss

Trout early life state toxicity

Static, acute, 48‐hour

toxicity test with Daphnia

magna

Daphnia toxicity test #2

Static, 72‐hour growth

inhibition toxicity test with

the green alga,

Pseudokirchneriella

subcapitata

Algae Toxicity Test #2
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Annual  Report of Form  10-KSB of  Calypte  Biomedical
Corporation (the "Company") for the year ended December 31, 2003 (the "Report"),
Anthony Cataldo, Executive Chairman of the Company, J. Richard George, President
and Chief  Executive  Officer of the  Company,  and  Richard  Brounstein,  Chief
Financial  Officer of the Company,  each hereby  certify,  pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

(1) to my knowledge,  the Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

/s/ Anthony J. Cataldo
----------------------
Anthony J. Cataldo
Executive Chairman
March 29, 2004

/s/ J. Richard George
---------------------
J. Richard George
President and Chief Executive Officer
March 29, 2004

/s/ Richard D. Brounstein
-------------------------
Richard D. Brounstein
Executive Vice President and Chief Financial Officer
March 29, 2004

A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
required by Section 906, has been provided to Calypte Biomedical Corporation and
will be retained by Calypte  Biomedical  and  furnished  to the  Securities  and
Exchange Commission or its staff upon request.



                                      II-4
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Partnership's interim financial statements for the six months ended September
30, 1995 and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER>                   1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                           2,952
<SECURITIES>                                         0
<RECEIVABLES>                                      312
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 3,999
<PP&E>                                          89,486
<DEPRECIATION>                                 (9,615)
<TOTAL-ASSETS>                                  84,578
<CURRENT-LIABILITIES>                              664
<BONDS>                                         24,478
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      59,088
<TOTAL-LIABILITY-AND-EQUITY>                    84,578
<SALES>                                              0
<TOTAL-REVENUES>                                 2,783
<CGS>                                                0
<TOTAL-COSTS>                                    1,989
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,023
<INCOME-PRETAX>                                  (229)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (229)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (229)
<EPS-PRIMARY>                                   (1.69)
<EPS-DILUTED>                                   (1.69)
        

</TABLE>
# Fourth Court of Appeals **San Antonio, Texas**

February 12, 20 20

No. 04

- 19

- 00818

- CV

IN THE INTEREST OF K.R.C. , A Child

, From the 25th Judicial District Court, Guadalupe County, Texas Trial Court No. 18

- 1390

- CV

- A Honorable Dulce Madrigal, Judge Presiding



### ORDER

The district clerk has filed the clerk’s record and a certificate of notice of appeal indicating the Honorable Dulce Madrigal tape recorded the proceeding. We therefore ORDER the trial court coordinator to contact either the court reporter or court recorder to file the reporter’s record by March 13, 2020

. If the court recorder prepares the reporter’s record, the court recorder must comply with Rules 13.2 and 34.6(a)(2) of the Texas Rules of Appellate Pro cedure by filing all tapes or audio

- storage devices on which the proceedings were recorded, any of the exhibits, and certified copies of logs prepared. See Tex. R. App. P. 13.2, 34.6(a)(2).

_________________________________ Beth Watkins , Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said court on this 12th day of February, 2020

.

___________________________________ MICHAEL A. CRUZ
, Clerk o f Court
Exhibit 32

DYNATEM, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-QSB of Dynatem, Inc. (the Company) for the fiscal quarter ending February 28, 2006, as filed with the Securities and Exchange Commission on the date hereof (the
Quarterly Report), the undersigned Chief Executive Officer and Chief Financial Officer of the Company each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:



| | 1. | The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | -------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

A signed original of this written statement required by Section 906 or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.

Dated: April 12, 2006



/s/ MICHAEL HORANMichael HoranChief Executive Officer




/s/ BELEN RAMOSBelen RamosChief Financial Officer
IN THE SUPREME COURT OF THE STATE OF DELAWARE

MICHAEL BROOMER

,

Defendant Below,

Appellant,

v.

STATE OF DELAWARE,

Appellee. §

§

§ No. 420, 2022

§

§ Court Below

— Superior Court

§ of the State of Delaware

§

§ Cr. ID No. 1504010863A ( N )

§

§

Submitted: March 15 , 202 3

Decided: A pril 24 , 2023

Before SEITZ , Chief Justice; VALIHURA and TRAYNOR

, Justices.

ORDE R

A fter consideration of the appellant’s opening brief and motion to appoint

counsel , the appellee’s motion to affirm, and the record on appeal

, 1 we conclude that

the judgment below should be affirmed on the basis of the Superior Court’s order,

dated October 28, 2022, summarily dismissing the appellant’s second motion for

postconviction relief

. T he appellant , Michael Broomer, clarifies on appeal that he

challenges the effectiveness of his postconviction counsel, but he s till failed to ple ad

with particularity new evidence creating a strong inference of actual innocence 2 or a

1 The amended opening brief filed after the motion to affirm is not properly before this Court, but

in any event would not change the outcome of this appeal.

2 Super. Cr. Crim R. 61(d)(2) (i).2

new, retroactive rule of constitutional law rendering his conviction s invalid. 3 Nor

has Broomer asserted any claim that the Superior Court lacked jurisdiction. 4

Broomer’s motion for appointment of counsel is denied as moot.

NOW, THEREFORE, IT IS ORDERED that the motion to affirm is

GRANTED

, the judgment of the Superior Court is AFFIRMED , and the motion fo r

appointment of counsel is denied as MOOT

.

BY THE COURT:

/s/ Gary F

. Traynor

Justice

3 Super. Ct. Crim. R. 61(d)(2) (ii)

. 4 Super. Ct. Crim. R. 61(i)(5).
Michigan Supreme Court

Lansing, Michigan

Stephen J. Markman

, Chief Justice

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen

Kurtis T. Wilder,

Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

May 17, 2017

s0510 

# Order

Clerk May 17, 2017

154435

JOSEPH BAYNESAN,

Plaintiff

- Appellee,

v SC: 154435

COA: 326132

Court of Claims: 14

- 000262

- MZ

WAYNE STATE UNIVERSITY,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the August 4 , 2016

judgment of the Court of Appeals is considered, and it is DENIED, because we are not

persuaded that the question presented should be reviewed by this Court.

B ERNSTEIN , J., did not participate.
Exhibit 10.2e
                   [LETTERHEAD OF ORANS, ELSEN & LUPERT, LLP]


                                                                    June 7, 1999


By Hand

Seth I. Truwit, Esq.
Epstein, Becker & Green, P.C.
250 Park Avenue
New York, New York  10177-0077

          Re: Promissory Note dated December 1996

Dear Seth:

     This will confirm the agreement  between  Edward A. Ullmann,  the Borrower,
and The WellCare Management Group, Inc.  ("WellCare"),  the Lender,  relating to
that certain  Promissory  Note dated  December  1996 in the  original  principal
amount of  $84,000.00.  Mr.  Ullmann and  WellCare  agree  that,  as of the date
hereof, the Promissory Note is canceled by WellCare, and any further payments of
principal and interest that might otherwise be due under the Promissory Note are
waived. Any unpaid interest to date, if any, is forgiven by WellCare.  It is the
intent of this  agreement  that no further  payments of  principal  or interest,
relating to any time period past or present,  need be made by Mr. Ullmann.  This
agreement is binding on any assignee of or successor in interest to WellCare.

     Please sign where indicated below to signify WellCare's  acceptance of this
agreement,  and return this to me. This will then be a binding  agreement on the
parties.

     I would  greatly  appreciate  it if you could  forward  to me the  canceled
Promissory Note at your earliest convenience.


                                                     Sincerely,

                                                     /s/ Robert L. Plotz
                                                    --------------------
                                                         Robert L. Plotz

Agreed and accepted on behalf of
The WellCare Management Group, Inc.:

/s/ Craig S. Dupont
-------------------
    Craig S. Dupont
    Acting President and Chief Executive Officer
# C_2016447EN.01001201.xml

| 1.12.2016 | EN | Official Journal of the European Union | C 447/12 |
| --- | --- | --- | --- |

1.12.2016

EN

Official Journal of the European Union

C 447/12

---

No state aid within the meaning of Article 61(1) of the EEA Agreement

(2016/C 447/08)

The EFTA Surveillance Authority considers that the following measure does not constitute State aid within the meaning of Article 61(1) of the EEA Agreement:

| Date of adoption of the decision | : | 12 September 2016 |
| --- | --- | --- |
| Case No | : | 79421 |
| Decision No | : | 165/16/COL |
| EFTA State | : | Norway |
| Title (and/or name of the beneficiary) | : | Export Credit Norway — pricing mechanism for market loans |
| Legal basis | : | Export Credit Act (Act of 22 June 2012 No 57) |
| Type of measure | : | No State aid |

Date of adoption of the decision

Date of adoption of the decision

:

12 September 2016

Case No

Case No

:

79421

Decision No

Decision No

:

165/16/COL

EFTA State

EFTA State

:

Norway

Title (and/or name of the beneficiary)

Title (and/or name of the beneficiary)

:

Export Credit Norway — pricing mechanism for market loans

Legal basis

Legal basis

:

Export Credit Act (Act of 22 June 2012 No 57)

Type of measure

Type of measure

:

No State aid

The authentic text of the decision, from which all confidential information has been removed, can be found on the EFTA Surveillance Authority’s website:

http://www.eftasurv.int/state-aid/state-aid-register/

---
§ 62.81 Supportive services grant closeout procedures. Supportive services grants will be closed out in accordance with the following procedures upon the date of completion: ( a ) No later than 90 days after the date of completion, the grantee must refund to VA any unobligated (unencumbered) balance of supportive services grant funds that are not authorized by VA to be retained by the grantee.
( b ) No later than 90 days after the date of completion, the grantee must submit all financial, performance and other reports required by VA to closeout the supportive services grant. VA may authorize extensions when requested by the grantee.
( c ) If a final audit has not been completed prior to the date of completion, VA retains the right to recover an appropriate amount after considering the recommendations on disallowed costs once the final audit has been completed.
(Authority: 38 U.S.C. 501, 2044)
# C_2007072EN.01004901.xml

| 29.3.2007 | EN | Official Journal of the European Union | C 72/49 |
| --- | --- | --- | --- |

29.3.2007

EN

Official Journal of the European Union

C 72/49

---

Action brought on 18 December 2006 by the EFTA Surveillance Authority against the Principality of Liechtenstein

(Case E-6/06)

(2007/C 72/24)

An action against the Principality of Liechtenstein was brought before the EFTA Court on 18 December 2006 by the EFTA Surveillance Authority, represented by Niels Fenger and Lorna Young, acting as Agents of the EFTA Surveillance Authority, 35, Rue Belliard, B-1040 Brussels.

The applicant claims that the Court should:

| 1. | Declare that by failing to adopt, or to notify the Authority of, the measures necessary to implement the Act referred to at point 32g of Annex XX to the Agreement on the European Economic Area (Directive 2002/49/EC of the European Parliament and of the Council of 25 June 2002 relating to the assessment and management of environmental noise), as adapted to the EEA Agreement by Protocol 1 thereto, within the time limit prescribed, the Principality of Liechtenstein has failed to fulfil its obligations under Article 14 of that Act and Article 7 EEA, and |
| --- | --- |

1.

Declare that by failing to adopt, or to notify the Authority of, the measures necessary to implement the Act referred to at point 32g of Annex XX to the Agreement on the European Economic Area (Directive 2002/49/EC of the European Parliament and of the Council of 25 June 2002 relating to the assessment and management of environmental noise), as adapted to the EEA Agreement by Protocol 1 thereto, within the time limit prescribed, the Principality of Liechtenstein has failed to fulfil its obligations under Article 14 of that Act and Article 7 EEA, and

Directive 2002/49/EC of the European Parliament and of the Council of 25 June 2002 relating to the assessment and management of environmental noise),

| 2. | Order the Principality of Liechtenstein to bear the costs of the proceedings. |
| --- | --- |

2.

Order the Principality of Liechtenstein to bear the costs of the proceedings.

Legal and factual background and pleas in law adduced in support:

| — | The case concerns the non-implementation of the environmental noise directive. |
| --- | --- |

—

The case concerns the non-implementation of the environmental noise directive.

| — | In the pre-litigation phase, Liechtenstein has not disputed that, by the expiry of the time limit, it had not taken the measures necessary to ensure implementation of the directive. |
| --- | --- |

—

In the pre-litigation phase, Liechtenstein has not disputed that, by the expiry of the time limit, it had not taken the measures necessary to ensure implementation of the directive.

---